Announcement PDF RNS Number : 1109G OptiBiotix Health PLC 25 March 2022 OptiBiotix Health plc ("OptiBiotix" or the "Company") PDMR Dealings OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, blood pressure and diabetes, announces that it was notified today of the following share purchases made by René Kamminga, CEO of Optibiotix Ltd: Date of transaction 23 March 2022 24 March 2022 Number purchased 10,000 2,656 of shares Price 40p 38p Following the above transactions, Mr Kamminga is interested in 55,844 ordinary shares in the Company, representing 0.06 per cent. of the Company's issued share capital. This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement. For further information, please contact: OptiBiotix Health plc Stephen O'Hara, Chief Executive www.optibiotix.com Contact via Walbrook below Cairn Financial Advisers LLP (NOMAD) Liam Murray / Jo Turner / Ludovico Lazzaretti Tel: 020 7213 0880 Cenkos Securities plc (Broker) Callum Davidson / Neil McDonald Michael Johnson / Russell Kerr (Sales) Tel: 020 7397 8900 Walbrook PR Ltd Mob: 07876 741 001 Anna Dunphy Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 1 Details of the person discharging managerial responsibilities/person closely associated a. Name 2 Reason for notification a. Position/Status PDMR b. Initial notification/ Initial Notification René Kamminga Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a. Name OptiBiotix Health Plc b. LEI 213800UKYQFT941QHS14 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a. Description of the financial instrument, type of instrument Ordinary shares of 2p each Identification Code ISIN: GB00BP0RTP38 b. Nature of the transaction Purchase of 12,656 ordinary shares in the Company c. Price(s) and volume(s) d. Volume(s) 40p 10,000 38p 2,656 Aggregated information - e. Price(s) per share Volume Price Date of the transaction 12,656 Average price of 39.6p 23 and 24s March 2022 f. Place of the transaction London Stock Exchange, AIM This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHSELFLIEESEDD